SISH (silver in situ hybridization) a new method to detect HER2/NEU gene amplification in breast cancer. comparison with fish

被引:0
|
作者
Papadopoulos, S. [1 ]
Perdiki, M. [1 ]
Papaioannou, D. [1 ]
Karyda, I. [2 ]
Evangelou, I. [1 ]
Razis, E. [3 ]
Skarpidi, E. [1 ]
Tsoli, E. [1 ]
Kosmidis, P. [3 ]
机构
[1] Hygeia Hosp Harvard Med Int, Dept Pathol, Athens, Greece
[2] Hygeia Hosp Harvard Med Int, Breast Unit, Athens, Greece
[3] Hygeia Hosp Harvard Med Int, Dept Oncol, Athens, Greece
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
123
引用
收藏
页码:55 / 55
页数:1
相关论文
共 50 条
  • [41] Silver-Enhanced In Situ Hybridization as an Alternative to Fluorescence In Situ Hybridization for Assaying HER2 Amplification in Clinical Breast Cancer
    Park, Kyeongmee
    Han, Sehwan
    Kim, Jung-Yeon
    Kim, Hyun-Jung
    Kwon, Ji Eun
    Gwak, Geumhee
    JOURNAL OF BREAST CANCER, 2011, 14 (04) : 276 - 282
  • [42] SILVER-ENHANCED IN SITU HYBRIDIZATION AS AN ALTERNATIVE TO FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSAYING HER2 AMPLIFICATION IN CLINICAL BREAST CANCER
    Han, S.
    Kim, J. S.
    Gwak, G.
    Park, K.
    ANNALS OF ONCOLOGY, 2012, 23 : 29 - 29
  • [43] Silver In Situ Hybridization (SISH);: Validation of a fully automated HER2 staining protocol
    Tubbs, RR
    Hicks, DG
    Pettay, JD
    Powell, WC
    Roche, PC
    Pang, L
    Klohe, EV
    Liu, W
    Powell, RD
    Hainfeld, JF
    Lounsbury, R
    Loftus, M
    Grogan, TM
    MODERN PATHOLOGY, 2006, 19 : 336A - 336A
  • [44] Evaluation of HER2 Gene Amplification in Breast Cancer Using Nuclei Microarray in Situ Hybridization
    Jiang, Huiyong
    Bai, Xiaoyan
    Zhang, Cheng
    Zhang, Xuefeng
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2012, 13 (05) : 5519 - 5527
  • [45] Prognostic utility of fluorescence in situ hybridization for determining HER2 gene amplification in breast cancer
    Kammori, Makoto
    Kurabayashi, Rie
    Kashi, Mitsuhiko
    Sakamoto, Akiko
    Yoshimoto, Masataka
    Amano, Sadao
    Kaminishi, Michio
    Yamada, Tetsu
    Takubo, Kaiyo
    ONCOLOGY REPORTS, 2008, 19 (03) : 651 - 656
  • [46] Validation of Dual-Color Dual In Situ Hybridization for HER2/neu Gene in Breast Cancer
    Rathi, Aditi
    Sahay, Ayushi
    Shet, Tanuja M.
    Patil, Asawari
    Desai, Sangeeta B.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2024, 148 (04) : 453 - 460
  • [47] Silver in situ hybridization (SISH);: Validation of a fully automated HER2 staining protocol
    Tubbs, RR
    Hicks, DG
    Pettay, JD
    Powell, WC
    Roche, PC
    Pang, L
    Klohe, EV
    Liu, W
    Powell, RD
    Hainfeld, JF
    Lounsbury, R
    Loftus, M
    Grogan, TM
    LABORATORY INVESTIGATION, 2006, 86 : 336A - 336A
  • [48] Immunohistochemical (IHC) HER-2/neu and Fluorescent-In-Situ Hybridization (FISH) Gene Amplification of Breast Cancer in Indian Women
    Singhai, Rajeev
    Patil, V. W.
    Patil, A. V.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2011, 12 (01) : 179 - 183
  • [49] Delineation of HER2 Gene Status in Korean Breast Cancers by Standardized Immunohistochemistry (IHC) and Silver In Situ Hybridization (SISH): Comparison of Local IHC Result with Central IHC and SISH Results
    Bae, Y. K.
    Gong, G.
    Kang, J.
    Lee, A.
    Cho, E. Y.
    Lee, J. S.
    Suh, K-S
    Lee, D. W.
    CANCER RESEARCH, 2010, 70
  • [50] Her2 Status in Gastric Adenocarcinoma: A Comparison of Immunohistochemistry (IHC), Fluorescent In-Situ Hybridization (FISH) and Dual Color Silver In-Situ Hybridization (SISH) Methods
    Zhou, C.
    Huntsman, D.
    Carter, B.
    Thomson, T.
    Lorette, J.
    Lee, S.
    Bell, L.
    Aubin, F.
    Woods, R.
    Lim, H.
    Gill, S.
    LABORATORY INVESTIGATION, 2011, 91 : 174A - 174A